Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (181-190 of 286) with videos related to

Pageof 29
Sort By:
Hematology (Amsterdam, Netherlands)|March 6, 2020
Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunctionJoi Ninomoto, Ahmad Mokatrin, Taisei Kinoshita, et al.
Annals of Internal Medicine|May 19, 2010
The vexing problem of guidelines and conflict of interest: a potential solutionGordon Guyatt, Elie A Akl, Jack Hirsh, et al.
Journal of Thrombosis and Thrombolysis|March 7, 2016
Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolismMichael B Streiff, Giancarlo Agnelli, Jean M Connors, et al.
Journal of Thrombosis and Thrombolysis|March 11, 2018
Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, BrazilRenato D Lopes, Patricia O Guimarães, Mark Crowther, et al.
Critical Care (London, England)|March 6, 2008
Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordingsWendy Lim, Paula Holinski, P J Devereaux, et al.
Journal of Thrombosis and Thrombolysis|October 8, 2021
Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valvesArjun K Pandey, Ke Xu, Li Zhang, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 10, 2005
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physiciansJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
Blood Advances|June 5, 2020
Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)Reza Mirza, Robby Nieuwlaat, Juan J López-Núñez, et al.
Thrombosis and Haemostasis|January 7, 2022
Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with EdoxabanAlexander P Benz, Lizhen Xu, John W Eikelboom, et al.
Blood Advances|February 25, 2020
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteersGenmin Lu, Pamela B Conley, Janet M Leeds, et al.
Pageof 29

Showing results (181-190 of 286) with videos related to

Sort By:
Pageof 29
Hematology (Amsterdam, Netherlands)|March 6, 2020
Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunctionJoi Ninomoto, Ahmad Mokatrin, Taisei Kinoshita, et al.
Annals of Internal Medicine|May 19, 2010
The vexing problem of guidelines and conflict of interest: a potential solutionGordon Guyatt, Elie A Akl, Jack Hirsh, et al.
Journal of Thrombosis and Thrombolysis|March 7, 2016
Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolismMichael B Streiff, Giancarlo Agnelli, Jean M Connors, et al.
Journal of Thrombosis and Thrombolysis|March 11, 2018
Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, BrazilRenato D Lopes, Patricia O Guimarães, Mark Crowther, et al.
Critical Care (London, England)|March 6, 2008
Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordingsWendy Lim, Paula Holinski, P J Devereaux, et al.
Journal of Thrombosis and Thrombolysis|October 8, 2021
Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valvesArjun K Pandey, Ke Xu, Li Zhang, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 10, 2005
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physiciansJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
Blood Advances|June 5, 2020
Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)Reza Mirza, Robby Nieuwlaat, Juan J López-Núñez, et al.
Thrombosis and Haemostasis|January 7, 2022
Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with EdoxabanAlexander P Benz, Lizhen Xu, John W Eikelboom, et al.
Blood Advances|February 25, 2020
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteersGenmin Lu, Pamela B Conley, Janet M Leeds, et al.
Pageof 29